Cynosure Management, LLC Axsome Therapeutics, Inc. Transaction History
Cynosure Management, LLC
- $854 Million
- Q2 2025
A detailed history of Cynosure Management, LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Cynosure Management, LLC holds 7,844 shares of AXSM stock, worth $980,500. This represents 0.1% of its overall portfolio holdings.
Number of Shares
7,844
Previous 5,405
45.12%
Holding current value
$980,500
Previous $630,000
29.84%
% of portfolio
0.1%
Previous 0.09%
Shares
4 transactions
Others Institutions Holding AXSM
# of Institutions
405Shares Held
37.4MCall Options Held
507KPut Options Held
540K-
Vanguard Group Inc Valley Forge, PA3.95MShares$493 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$412 Million0.01% of portfolio
-
Bvf Inc San Francisco, CA1.69MShares$211 Million6.93% of portfolio
-
Rtw Investments, LP New York, NY1.52MShares$190 Million2.43% of portfolio
-
Macquarie Group LTD Australia, C31.14MShares$142 Million0.15% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $5.36B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...